Glucosylceramide and glucosylsphingosine analysis V.2

Research Community
Research Community

ASAP supports three programs and serves as a member of multiple consortia to advance research for the benefit of the global Parkinson’s disease community.
Explore
Highlights
Highlights

ASAP shares the impact that our initiative, network, and supported programs have had on providing new insights into Parkinson’s disease. Discover news, interviews, awards, and annual impact.
Explore
Open Science
Open Science

ASAP is dedicated to facilitating a research environment where meaningful collaboration, research-enabling resources, and data sharing provides the answers we need to understand, diagnose, and treat Parkinson’s disease. Discover our open science philosophy.
Explore
Tools & Resources
Tools & Resources

ASAP is committed to developing and openly sharing research outputs, including data, code, protocols, and key lab materials, to help the scientific community build upon existing work.
Explore

Description

This protocol was used to analysis glucosylceramide and glucosylsphingosine levels in mouse brain and liver. It was also described in previous publication (Mol Cell Neurosci. 2020 Jan:102:103451, doi: 10.1016)

Identifier (DOI)

10.17504/protocols.io.261gedk8wv47/v2

Team

Team Vangheluwe

Program

Collaborative Research Network

Theme

PD Functional Genomics

Meet the Authors

Tae-Un Han, PhD

Key Personnel: Team Vangheluwe,

National Institute of Health
Carley Corado

External Collaborator

Glucosylceramide and glucosylsphingosine analysis V.2

Output Details

Meet the Authors

Tae-Un Han, PhD

Carley Corado

Related Research

western blot data of ‘A new selection strategy to enrich dopaminergic neurons facilitates comparisons between patient iPSC-derived lines’

Jess western blot automated system

HT707